Metoprolol Tartrate Accord Healthcare

Metoprolol Tartrate, the active ingredient in Metoprolol Tartrate Accord Healthcare, is a beta blocker presented as an oral tablet for oral use. It lowers blood pressure, relieves angina, and helps control heart rhythm in adults with cardiovascular conditions.

GNH USA supplies Metoprolol Tartrate Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured bulk shipments and regulatory compliance across multiple markets. The company leverages a robust distribution network to meet demand in both developed and emerging healthcare systems.

Metoprolol Tartrate is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: reduces systolic and diastolic pressure to target levels. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival by limiting cardiac workload after an acute event. - Heart failure: lowers heart rate and contractility to improve ventricular filling and reduce symptoms. - Cardiac arrhythmias: stabilises abnormal heart rhythms by slowing conduction through the AV node.

Metoprolol Tartrate may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness, especially on standing. - Cold extremities such as hands and feet. - Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects: - Bradycardia (abnormally slow heart rate). - Symptomatic hypotension (low blood pressure). - AV block or other serious cardiac conduction disturbances. - Bronchospasm in patients with reactive airway disease. - Severe allergic reactions including rash, swelling, or anaphylaxis.

Before prescribing Metoprolol Tartrate, clinicians should evaluate the patient's overall cardiovascular status and monitor for potential complications.

- Assess cardiovascular status before initiating: obtain baseline blood pressure and heart rate. - Monitor for signs of heart‑failure exacerbation: watch for peripheral edema, sudden weight gain, or dyspnoea. - Use caution in patients with asthma or COPD: β‑blockade may provoke bronchospasm. - Avoid abrupt discontinuation: taper the dose to prevent rebound hypertension or tachycardia. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Metoprolol Tartrate can interact with several drug classes, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Verapamil or diltiazem: combined use may cause severe bradycardia or AV block. - Clonidine: abrupt withdrawal of clonidine while on Metoprolol can precipitate hypertensive crisis. - Non‑selective β‑blockers: concurrent use increases risk of excessive β‑blockade.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): may potentiate hypotensive effects; monitor electrolytes. - NSAIDs: can reduce antihypertensive efficacy of Metoprolol. - Antidiabetic agents (insulin, sulfonylureas): Metoprolol may mask hypoglycaemia symptoms; adjust glucose monitoring.